Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Leal T et al. – The authors report a case of bevacizumab (BEV)–induced thrombocytopenia in a 36–year–old woman treated with BEV as a single–agent for a recurrent high–grade glioma. The thrombocytopenia was both reversible and reproducible on multiple treatment cycles. This is a rare complication that has not been previously reported.

Related Articles

Six-Month Follow-Up of Patients With In-Hospital Thrombocytopenia During Heparin-Based Anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] Registry)
The American Journal of Cardiology, 10/28/09    Relevance Score: 91%

Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09    Relevance Score: 90%

Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism
American Journal of Medicine, 10/02/09    Relevance Score: 89%

Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia
Pediatrics, 10/28/09    Relevance Score: 88%

Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09    Relevance Score: 87%

Today in Neurologic Oncology...keeping you current

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/04/09

Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address